RISKGUARD HEREDITARY CANCER TEST Trademark

Trademark Overview


On Friday, November 22, 2024, a trademark application was filed for RISKGUARD HEREDITARY CANCER TEST with the United States Patent and Trademark Office. The USPTO has given the RISKGUARD HEREDITARY CANCER TEST trademark a serial number of 98868555. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, August 13, 2025. This trademark is owned by Exact Sciences Corporation. The RISKGUARD HEREDITARY CANCER TEST trademark is filed in the Pharmaceutical Products category with the following description:

Preparations for detecting genetic predispositions for medical purposes, namely, hereditary cancer screening test comprised of molecular diagnostic reagents and assays for use in disease detection by detecting DNA, chromosomal changes, abnormalities or mutations for detection of genes for hereditary cancer, identifying hereditary risk associated with cancer and identifying predisposition to cancer; Reagents for medical use; Medical diagnostic assays for testing of body fluids; Medical diagnostic reagents; Medical diagnostic assays for use in disease detection and screening related to cancer
riskguard hereditary cancer test

General Information


Serial Number98868555
Word MarkRISKGUARD HEREDITARY CANCER TEST
Filing DateFriday, November 22, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateWednesday, August 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized mark RISKGUARD HEREDITARY CANCER TEST, stacked.
Goods and ServicesPreparations for detecting genetic predispositions for medical purposes, namely, hereditary cancer screening test comprised of molecular diagnostic reagents and assays for use in disease detection by detecting DNA, chromosomal changes, abnormalities or mutations for detection of genes for hereditary cancer, identifying hereditary risk associated with cancer and identifying predisposition to cancer; Reagents for medical use; Medical diagnostic assays for testing of body fluids; Medical diagnostic reagents; Medical diagnostic assays for use in disease detection and screening related to cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"HEREDITARY CANCER TEST"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameExact Sciences Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMadison, WI 53719

Trademark Events


Event DateEvent Description
Friday, November 22, 2024NEW APPLICATION ENTERED
Wednesday, January 29, 2025DIVISIONAL REQUEST RECEIVED
Wednesday, January 29, 2025TEAS REQUEST TO DIVIDE RECEIVED
Friday, January 31, 2025ASSIGNED TO LIE
Wednesday, July 23, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 30, 2025ASSIGNED TO EXAMINER
Tuesday, August 5, 2025NON-FINAL ACTION WRITTEN
Tuesday, August 5, 2025NON-FINAL ACTION E-MAILED
Tuesday, August 5, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 13, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, August 13, 2025EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 13, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 13, 2025EXAMINER'S AMENDMENT ENTERED
Wednesday, August 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 30, 2025DIVISIONAL PROCESSING COMPLETE
Thursday, April 10, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL